{"id":110115,"date":"2024-07-10T10:37:07","date_gmt":"2024-07-10T08:37:07","guid":{"rendered":"https:\/\/ivi-fertility.com\/?p=110115"},"modified":"2024-07-12T10:37:15","modified_gmt":"2024-07-12T08:37:15","slug":"testicular-cancer","status":"publish","type":"post","link":"https:\/\/ivi-fertility.com\/blog\/testicular-cancer\/","title":{"rendered":"IVI studies the effects of chemotherapy on sperm DNA in testicular cancer patients"},"content":{"rendered":"

The incidence of testicular cancer is continuously increasing across most of Europe. A study by the International Agency for Research on Cancer (IARC)<\/a> estimates that one in three cases of this disease occurs in European countries.<\/p>\n

This cancer has a high survival rate. However, it impacts significantly male fertility, primarily affecting men aged 20 to 34<\/strong>. IVI presented an innovative study on the effects of chemotherapy in cases of testicular cancer at the 40th edition of ESHRE.<\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n